Iwona Golonka | Pharmacology | Women Researcher Award

Posted on by ScienceFather

Dr. Iwona Golonka | Pharmacology | Best Researcher Award

Assistant Professor at Department of Physical Chemistry and Biophysics Pharmaceutical Faculty Wroclaw Medical University, Poland 

Dr. Iwona Golonka, an assistant professor at Wroclaw Medical University, is a distinguished researcher specializing in physical chemistry and pharmaceutical sciences. Over a career spanning more than two decades, she has made significant contributions to interdisciplinary research, blending theoretical chemistry with practical applications in drug development and antimicrobial therapies. She has authored 15 scientific papers with a cumulative impact factor of 48.378, including high-impact work published in top journals. Dr. Golonka’s innovative achievements include patents for novel pharmaceutical compositions, such as flotation tablets with enhanced drug delivery properties. She has collaborated with leading institutions in Poland and abroad, gaining expertise in techniques like DSC, HPLC, and chemometric methods. As a mentor and educator, she has guided numerous master’s theses and contributed to academic materials for pharmacy students. Recognized through prestigious awards and distinctions, Dr. Golonka exemplifies dedication to advancing science, education, and innovation in pharmaceutical research.

Professional Profile

Education

Dr. Iwona Golonka’s educational journey is rooted in a strong foundation in chemistry, beginning with her Master’s degree in Environmental Chemistry from the University of Wrocław in 1999. Her studies focused on understanding environmental systems through the lens of chemistry, setting the stage for her multidisciplinary approach to research. Following her Master’s, Dr. Golonka pursued full-time doctoral studies in inorganic chemistry at the same university, specializing in coordination chemistry within the Electron Paramagnetic Resonance (EPR) Group. She earned her Ph.D. in Chemical Sciences in 2006, where her research emphasized the intricate interactions of coordination compounds. Throughout her academic development, Dr. Golonka further honed her skills through research internships, such as a Socrates/Erasmus program at the University of Helsinki, where she investigated radical reaction kinetics in atmospheric conditions. Her diverse and rigorous educational background has enabled her to merge theoretical knowledge with practical applications, significantly contributing to pharmaceutical and physical chemistry.

Professional Experience

Dr. Iwona Golonka has been an assistant professor at Wroclaw Medical University since 2003, where she contributes to both research and education within the Faculty of Pharmacy’s Department of Physical Chemistry and Biophysics. Her professional experience spans various interdisciplinary research areas, with a particular focus on pharmaceutical sciences and biophysical techniques. Dr. Golonka has led and contributed to numerous collaborative research projects, exploring topics such as antimicrobial peptides, drug stability, and innovative drug delivery systems. She has developed expertise in analytical techniques like DSC, HPLC, and chemometric methods through research stays at institutions such as the Medical University of Gdańsk and Poznań University of Technology. Additionally, she has played a key role in mentoring students, guiding several master’s theses and contributing to the development of academic materials. Her involvement in numerous national and international collaborations highlights her ability to bridge theory and practice in cutting-edge pharmaceutical research.

Research Interests

Dr. Iwona Golonka’s research interests lie at the intersection of physical chemistry and pharmaceutical sciences. She focuses on understanding the molecular interactions and physicochemical properties of substances, particularly in the context of drug development and delivery. A key area of her research involves the stability and formulation of active pharmaceutical ingredients (APIs), where she employs advanced techniques such as Differential Scanning Calorimetry (DSC) and High-Performance Liquid Chromatography (HPLC). Dr. Golonka has a particular interest in antimicrobial peptides and their potential applications in treating conditions like acne vulgaris. She explores how these peptides interact with bacterial cellulose carriers to enhance their therapeutic effectiveness. Additionally, her research delves into the development of novel drug delivery systems, such as flotation tablets that provide prolonged therapeutic effects on the gastric mucosa. Through her work, Dr. Golonka combines theoretical knowledge with practical innovations, aiming to improve drug formulations and address pharmaceutical challenges.

Awards and Honors

Dr. Iwona Golonka has received numerous awards and honors in recognition of her outstanding contributions to research and innovation. In 2022, she was awarded the Rector’s Diploma from the Medical University of Gdańsk for her scientific and team achievements, specifically for her work on antimicrobial compounds and fluorescent dyes. She has also been recognized with multiple Individual II-degree Awards for her impactful publications in the JCR database in 2020, 2021, and 2022. Dr. Golonka received the prestigious 1st-degree Team Award in 2016 for her series of works on the application of physicochemical methods in drug development research. That same year, her team won a distinction in the national Eureka! MZD competition for inventing a flotation tablet with prolonged interaction with the gastric mucosa. Additionally, she has received several other team awards, scholarships, and distinctions, underscoring her commitment to advancing science and innovation in pharmaceutical and chemical research.

Conclusion

Dr. Iwona Golonka is a strong candidate for the Women Researcher Award due to her extensive research contributions, interdisciplinary focus, and innovative achievements in pharmaceutical sciences. Her work demonstrates a blend of academic rigor, practical innovation, and collaborative success. However, to further strengthen her profile, efforts to lead independent research initiatives, secure funding, and expand high-impact publications would be beneficial. Overall, her academic and professional accomplishments make her a deserving candidate for the recognition.

Publications Top Noted

  • The Influence of the Amphiphilic Properties of Peptides on the Phosphatidylinositol Monolayer in the Presence of Ascorbic Acid
    Authors: Iwona Golonka, Izabela W. Łukasiewicz, Aleksandra Sebastiańczyk, Katarzyna E. Greber, Wiesław Sawicki, Witold Musiał
    Year: 2024
    Citation: 10.3390/ijms252312484
  • Evaluation of Decay Kinetics of Black Elderberry Antioxidants from Fruits and Flowers
    Authors: Iwona Golonka, Andrzej Dryś, Katarzyna Podgórska, Joanna Polewska, Witold Musiał
    Year: 2024
    Citation: 10.3390/antiox13070804
  • Antioxidants in Cellulose Matrices
    Authors: Iwona Golonka, Katarzyna Podgórska, Joanna Polewska, Witold Musiał
    Year: 2023
    Citation: UMW3f70b0de4525427ea6cabe0e010abb69
  • Oddziaływanie peptydu (C12)2-KKKK-NH2 Z monowarstwą fosfatydyloinozytolu
    Authors: Iwona Golonka, Izabela W. Łukasiewicz, Katarzyna E. Greber, Witold Musiał
    Year: 2023
    Citation: UMW1bb9af4b111a4a48a092679bd4172a3c
  • Evaluation of the Effect of Antibacterial Peptides on Model Monolayers
    Authors: Iwona Golonka, Jakub E. Pucułek, Katarzyna E. Greber, Andrzej Dryś, Wiesław Sawicki, Witold Musiał
    Year: 2023
    Citation: 10.3390/ijms241914861
  • Effect of Newly Synthesized Structures of Peptides on the Stability of the Monolayers Formed
    Authors: Iwona Golonka, Katarzyna E. Greber, Bartłomiej M. Szyja, Patrycja P. Petrus, Jakub E. Pucułek, Witold Musiał
    Year: 2023
    Citation: 10.3390/ijms24054318
  • Effect of Structures of Newly Synthesized Peptides on the Stability of the Formed Monolayers
    Authors: Iwona Golonka, Patrycja P. Petrus, Jakub E. Pucułek, Katarzyna E. Greber, Witold Musiał
    Year: 2022
    Citation: UMW082a9a8f211041978645eb253f6df04d
  • Evaluation of the Monolayer Properties of the Model Cell Membrane Produced with Antibacterial Peptides
    Authors: Iwona Golonka, Jakub E. Pucułek, Patrycja P. Petrus, Katarzyna E. Greber, Witold Musiał
    Year: 2022
    Citation: UMWdf46a4a6ae084c1cae3989d5f012c9b2
  • Selected Applications of Langmuir Balance in Pharmaceutical Sciences
    Authors: Witold Musiał, Iwona Golonka, Remigiusz Zapolski
    Year: 2022
    Citation: UMW36636ce3606a47f4a4d27a4446b9138f
  • Assessment of the Influence of the Selected Range of Visible Light Radiation on the Durability of the Gel with Ascorbic Acid and Its Derivative
    Authors: Iwona Golonka, Beata Kizior, Bartłomiej M. Szyja, Mateusz P. Damek, Witold Musiał
    Year: 2022
    Citation: 10.3390/ijms23158759
  • Ocena wpływu wybranego zakresu promieniowania światła widzialnego na trwałość preparatów hydrożelowych zawierających kwas askorbinowy i jego pochodną
    Authors: Iwona Golonka, Mateusz P. Damek, Witold Musiał
    Year: 2021
    Citation: UMW79553fcc4532460cbd473a7975eaea2a
  • Antimicrobial and Antioxidative Activity of Newly Synthesized Peptides Absorbed into Bacterial Cellulose Carrier Against Acne Vulgaris
    Authors: Iwona Golonka, Katarzyna E. Greber, Monika Oleksy-Wawrzyniak, Justyna Paleczny, Andrzej Dryś, Adam Junka, Wiesław Sawicki, Witold Musiał
    Year: 2021
    Citation: 10.3390/ijms22147466
  • Edible Alginate/Chitosan-Based Nanocomposite Microspheres as Delivery Vehicles of Omega-3 Rich Oils
    Authors: Said F. Hamed, Ayat F. Hashim, Hoda A. Abdel Hamid, Kamel A. Abd-Elsalam, Iwona Golonka, Witold Musiał, Ibrahim M. El-Sherbiny
    Year: 2020
    Citation: 10.1016/j.carbpol.2020.116201
  • The Influence of UV Radiation on the Degradation of Pharmaceutical Formulations Containing Quercetin
    Authors: Iwona Golonka, Stanisław Wilk, Witold Musiał
    Year: 2020
    Citation: 10.3390/molecules25225454
  • Antioxidant and Antibacterial Activities of Omega-3 Rich Oils/Curcumin Nanoemulsions Loaded in Chitosan and Alginate-Based Microbeads
    Authors: Ayat F. Hashim, Said F. Hamed, Hoda A. Abdel Hamid, Kamel A. Abd-Elsalam, Iwona Golonka, Witold Musiał, Ibrahim M. El-Sherbiny
    Year: 2019
    Citation: 10.1016/j.ijbiomac.2019.08.085

Rassa Pegahi | Pharmacology | Best Researcher Award

Posted on by ScienceFather

Dr. Rassa Pegahi | Pharmacology | Best Researcher Award

Global medical affairs manager at UPSA, France

Dr. Rassa Pegahi, a seasoned Global Medical Affairs Manager and Scientific Advisor, has over 18 years of experience in medical affairs and clinical operations. She has led significant projects in various therapeutic areas, including pain, cold and flu, stroke, wound healing, oncology, and Alzheimer’s genetics. With a Ph.D. in Cell and Molecular Biology from the University of Rouen, Dr. Pegahi has extensive expertise in clinical data generation, regulatory submissions, and clinical trial management. Her work includes publishing in international journals, building partnerships with Key Opinion Leaders (KOLs), and supporting product development. Additionally, Dr. Pegahi has trained medical professionals and managed cross-functional teams, showcasing her commitment to advancing healthcare knowledge. Proficient in English, French, and Persian, she is well-equipped for international collaboration. Her broad research experience and leadership make her a distinguished figure in medical research and an asset in the pursuit of innovative health solutions.

Professional Profile

Education

Dr. Rassa Pegahi has a robust academic background centered around molecular biology, clinical research, and project management. She earned her Ph.D. in Cell and Molecular Biology from the University of Rouen, with earlier studies culminating in a Master’s in Cell Biology (Molecular Genetics) and a Master’s in Bio-molecular Chemistry from the same institution and Montpellier University, respectively. She also holds a Certificate of Competent Person in Radioactive Protection from Rouen University, underscoring her technical qualifications in medical research. In 2010, she completed a Clinical Research Project Manager diploma from Paris Descartes University Medical School, furthering her expertise in research management. Dr. Pegahi continued her professional education by obtaining a Clinical Research graduate certification from Clinact-CRO Training Center and a Green Belt certificate from 3M France, reflecting her commitment to quality and process improvement. This multidisciplinary education has empowered her extensive career in global medical affairs and clinical operations.

Professional Experience

Dr. Rassa Pegahi brings over 18 years of experience in medical affairs and clinical operations across diverse therapeutic areas, including pain management, wound healing, and oncology. Since 2020, she has served as Global Medical Affairs Manager at UPSA, where she oversees clinical data strategies, builds scientific partnerships, and supports product development for both prescription and OTC drugs. Previously, as Head of Clinical Operations at Acticor-Biotech, Dr. Pegahi managed clinical trials for stroke immunotherapy, fostering relationships with investigators and handling CRO partnerships. Her role at 3M France involved directing clinical operations for wound healing and vascular access medical devices, as well as authoring scientific publications and organizing conferences. Earlier in her career, she coordinated clinical trials in urology and neurology at Rouen Hospital and contributed to basic research in onco-hematology and molecular genetics. Dr. Pegahi’s extensive, cross-functional experience highlights her leadership and expertise in advancing healthcare solutions globally.

Research Interests

Dr. Rassa Pegahi’s research interests lie at the intersection of clinical innovation and patient-centered healthcare advancements. With a foundation in molecular and cellular biology, her work spans a broad spectrum, including oncology, immunotherapy for stroke, and wound healing technologies. She is particularly interested in developing and validating clinical protocols that improve patient outcomes, evidenced by her focus on investigational drug development, medical devices, and biomarker research in cancer. Dr. Pegahi is also invested in bridging science with practical healthcare applications, collaborating with Key Opinion Leaders (KOLs) to foster medical advancements and ensuring regulatory compliance in clinical studies. Her role in bibliographic research, competitive product analysis, and scientific communication highlights her commitment to staying at the forefront of medical knowledge. Additionally, her experience with pharmacovigilance and market access reflects a keen interest in ensuring patient safety and broadening access to innovative therapeutic solutions in global healthcare.

Awards and Honors

Dr. Rassa Pegahi has received numerous accolades throughout her distinguished career, reflecting her significant contributions to the field of medical affairs and clinical operations. She has been recognized for her leadership in advancing clinical trials and medical research, particularly in areas such as oncology, stroke immunotherapy, and wound healing. Dr. Pegahi’s expertise has been instrumental in the successful development and management of investigational medicinal products and medical devices, earning her trust and recognition from Key Opinion Leaders (KOLs) and scientific communities globally. Her ability to collaborate with cross-functional teams and deliver impactful research has positioned her as a key figure in both scientific and medical spheres. Additionally, Dr. Pegahi’s active participation in international conferences and symposia underscores her commitment to ongoing professional development and knowledge-sharing. While specific formal awards and honors are not listed, her widespread recognition within the healthcare industry and scientific community attests to her exceptional contributions and influence in the field.

Conclusion

Rassa Pegahi has a well-rounded, impactful background in medical affairs, with a strong foundation in clinical research and an extensive publication record. Her comprehensive experience in clinical trials, bibliographic research, and scientific communication make her a strong candidate for the Best Researcher Award. Addressing the suggested areas for improvement could further elevate her profile, potentially positioning her among the top contenders for this honor.

Publications Top Noted

  • Title: An Updated Review on the Metabolite (AM404)-Mediated Central Mechanism of Action of Paracetamol (Acetaminophen): Experimental Evidence and Potential Clinical Impact
    • Authors: Mallet, C., Desmeules, J., Pegahi, R., Eschalier, A.
    • Journal: Journal of Pain Research
    • Year: 2023
    • Volume: 16
    • Pages: 1081–1094
    • Citations: 17
  • Title: Exudates absorption and proteases trapping in venous leg ulcers
    • Authors: Humbert, P., Courderot-Masuyer, C., Robin, S., Oster, D., Pegahi, R.
    • Journal: Journal of Wound Care
    • Year: 2017
    • Volume: 26
    • Issue: 6
    • Pages: 346–348
    • Citations: 10
  • Title: Secretion of MMP-2 and MMP-9 induced by VEGF autocrine loop correlates with clinical features in childhood acute lymphoblastic leukemia
    • Authors: Poyer, F., Coquerel, B., Pegahi, R., Vannier, J.-P., Lamacz, M.
    • Journal: Leukemia Research
    • Year: 2009
    • Volume: 33
    • Issue: 3
    • Pages: 407–417
    • Citations: 27
  • Title: Spontaneous and cytokine-evoked production of matrix metalloproteinases by bone marrow and peripheral blood pre-B cells in childhood acute lymphoblastic leukaemia
    • Authors: Pegahi, R., Poyer, F., Legrand, E., Vannier, J.-P., Lamacz, M.
    • Journal: European Cytokine Network
    • Year: 2005
    • Volume: 16
    • Issue: 3
    • Pages: 223–232
    • Citations: 13

Ana Margarida Passos Borges | Pharmacology | Best Researcher Award

Posted on by ScienceFather

Mrs. Ana Margarida Passos Borges | Pharmacology | Best Researcher Award

Aluna de Doutoramento at CIMO, Portugal

Ana Margarida Passos Borges is a promising young researcher and PhD candidate in Pharmacy and Health at the University of Salamanca. She holds a Master’s in Applied Health Sciences and a Bachelor’s in Pharmacy from the Institute of Bragança, Portugal. Currently, Ana is a research fellow at the Mountain Research Center (CIMO) at the Institute of Bragança, focusing on the biomedical potential of Sericin, a silk industry by-product. Her research interests span health, pharmacy, medical devices, sustainability, and natural products. Ana has published several articles in notable journals, including on wound healing and the medicinal applications of terpenoids. In addition to her research, she is passionate about teaching and has facilitated various learning projects, including leading diverse teams in health education initiatives. Ana also holds multiple certifications in first aid, pedagogy, and cell culture, showcasing her commitment to both academic and professional growth.

Professional Profile

Education

Ana Margarida Passos Borges has a strong educational background in pharmacy and health sciences. She is currently pursuing a PhD in Pharmacy and Health at the University of Salamanca, Spain, where she focuses on advancing her research in these fields. Prior to her doctoral studies, Ana completed a Master’s degree in Applied Health Sciences, specializing in Community Intervention, at the Institute of Bragança, Portugal, in 2022. She also holds a Bachelor’s degree in Pharmacy from the same institution, earned in 2020. In addition to her formal degrees, Ana has participated in various supplementary courses to enhance her skills. These include certifications in first aid and basic life support, pedagogical training for educators, and courses on cell culture techniques and the medicinal applications of terpenoids. Her academic journey reflects a commitment to continuous learning and professional development in the areas of health, pharmacy, and research.

Professional Experience

Ana Margarida Passos Borges has gained valuable professional experience in both research and pharmacy practice. She is currently a research fellow at the Mountain Research Center (CIMO) at the Institute of Bragança, where she works on the project “Sericina: A Silk Industry By-product with Biomedical Potential,” funded by the Fundação para a Ciência e Tecnologia. In this role, she conducts research under the guidance of renowned scientists, focusing on innovative biomedical applications. Prior to this, Ana worked as a pharmacy technician at Farmácia Confiança and Farmácia Bem Saúde, where she managed day-to-day pharmacy tasks and provided direct patient care. She has also co-facilitated a project at the Institute of Bragança, titled “A Sustainable Smile,” which involved collaborating with diverse teams to develop health education initiatives. Ana’s blend of research experience and practical pharmacy knowledge highlights her versatile skills in both academic and clinical settings.

Research Interests

Ana Margarida Passos Borges’ research interests are focused on several key areas within health and pharmacy. Her primary focus is on exploring the biomedical potential of natural products, particularly those derived from plants and by-products of industries, such as Sericin, a silk industry waste. She investigates the therapeutic applications of these compounds, particularly in wound healing and biomedical innovations. Ana is also interested in sustainability, aiming to integrate eco-friendly practices into healthcare and pharmaceutical solutions. Additionally, her research delves into the development of medical devices and the role of active methodologies in health education. She is passionate about enhancing the quality of healthcare education, particularly through the use of innovative teaching approaches like active learning. With a strong foundation in community health intervention, Ana is dedicated to improving public health through research on natural products, health education, and sustainable practices within the healthcare sector.

Awards and Honors

Ana Margarida Passos Borges has received recognition for her contributions to research and education. Her dedication to advancing biomedical and health sciences is evident in her recent publications, such as her review articles on Sericin, Chelidonium majus L., and terpenoids in wound healing and medicinal applications. These publications have been featured in prestigious journals and conferences, highlighting her growing impact in the field of pharmaceutical sciences. Additionally, her involvement in projects like “A Sustainable Smile” has earned her acknowledgment for her collaborative and innovative approaches in health education. Ana’s excellence in both research and teaching has led to her being awarded a PhD research fellowship at the Mountain Research Center (CIMO) at the Institute of Bragança. Her academic excellence and commitment to sustainability and innovation continue to position her as a rising star in the fields of health, pharmacy, and biomedical research.

Conclusion

Ana Margarida Passos Borges is a highly promising and dedicated researcher with a strong academic foundation and growing contributions in the fields of pharmacy, health science, and sustainable healthcare innovation. Her research output and academic initiatives are commendable, and her dedication to improving health through scientific exploration is evident in her work. To further enhance her candidacy for the Best Researcher Award, focusing on increasing the practical applications of her research, assuming leadership positions, and expanding international collaborations could help her reach the next level in her career. Nonetheless, her current achievements reflect a researcher who is already making meaningful contributions to the scientific community.

Publications Top Noted

  • Borges, Ana Margarida; Martin, M.L.; Vaz, Josiana Adelaide; Calhelha, Ricardo C. (2024). “Enhancing Wound Healing: A Comprehensive Review of Sericin and Chelidonium majus L. as Potential Dressings.” Materials, August 2024. DOI: 10.3390/ma17174199.
  • Borges, Ana; Calvo, María Luisa Martín; Vaz, Josiana; Calhelha, Ricardo C. (2024). “Investigating Therapeutic Synergy: Cell Assays Uncover the Potential of Sericin and Chelidonium Majus L. for a Possible Wound Dressing.” Presented at Encontro Ciência 2024 – Encontro com a Ciência e a Tecnologia em Portugal, June 2024.
  • Borges, Ana; Calvo, María Luisa Martín; Vaz, Josiana; Calhelha, Ricardo C. (2024). “Exploring the Therapeutic Synergy: Comprehensive Assays Reveal Sericin and Chelidonium Majus L.’s Potential for Wound Dressing Innovation.” Presented at Polymers 2024 – Polymers for a Safe and Sustainable Future, May 2024.
  • Borges, A.; Mandim, F.; Heleno, S.A.; Calhelha, R.C. (2024). “Application and Medicinal Use of Terpenoids.” Austin Journal of Analytical and Pharmaceutical Chemistry, February 2024.
  • Borges, Ana Margarida Passos (2022). “Ensino – aprendizagem em ciências de saúde: metodologias ativas no ensino superior.” Master’s Thesis, 2022. Available at http://hdl.handle.net/10198/26338.
  • Borges, Ana; Pereira, Fernando A.; Barbedo, Inês; Almeida, João P.; Cabo, Paula; Rodrigues, Pedro; Ferro-Lebres, Vera; et al. (2022). “Skill Development in Health Sciences: Active Methodologies in Higher Education.” ICOPEV22 – 5th International Conference on Production Economics and Project Evaluation. DOI: 10.53681/2023.l03/03.

Daniel Tristan Osanlóo | Pharmacology | Best Researcher Award

Posted on by ScienceFather

Dr. Daniel Tristan Osanlóo | Pharmacology | Best Researcher Award

Formulation Scientist at Recipharm Pharmaceutical Development, Sweden

Dr. Daniel Tristan Osanloo is a dedicated researcher and formulation scientist based in Uppsala, Sweden. He recently completed his PhD at RISE AB/LTH, focusing on “Alternative drying technologies for biologics,” where he utilized advanced instruments such as freeze-dryers and spray dryers. His industry experience includes roles at prominent companies like Recipharm, Orexo AB, and AstraZeneca, where he contributed to the development of innovative pharmaceutical formulations. Dr. Osanloo has demonstrated strong leadership skills through his involvement in various community initiatives and board memberships, fostering collaboration and engagement. His academic background includes a pharmacy degree from Uppsala University, complemented by a master’s thesis on the de-agglomeration of micronized active pharmaceutical ingredients. With a commitment to advancing pharmaceutical sciences, Dr. Osanloo is poised to make significant contributions to the field and is an excellent candidate for recognition as a leading researcher.

Professional Profile

Education

Dr. Daniel Tristan Osanloo holds a PhD in Pharmaceutical Sciences from RISE AB and Lund University (LTH), which he completed in 2024. His doctoral research focused on “Alternative drying technologies for biologics,” exploring innovative methods beyond freeze-drying to enhance product stability and efficacy. Prior to his PhD, he earned a comprehensive pharmacy degree (300 hp) from Uppsala University, where he studied from 2011 to 2016. During his academic tenure, he conducted a master’s thesis project at Orexo AB, investigating the de-agglomeration of micronized active pharmaceutical ingredients, which laid the groundwork for his research expertise. Dr. Osanloo also completed an internship at Kronans Apotek, where he honed his communication skills and gained practical pharmacy experience. His educational background reflects a strong foundation in pharmaceutical sciences, complemented by hands-on training and a focus on innovative research methodologies.

Professional Experience

Dr. Daniel Tristan Osanloo has a robust professional background in pharmaceutical development and research. Currently, he serves as a Formulation Scientist at Recipharm Pharmaceutical Development in Solna, where he is responsible for developing solid, semi-solid, and liquid formulations, managing manufacturing methods, and preparing technical documentation for product stability studies. Previously, he completed his PhD at RISE AB/LTH, focusing on alternative drying technologies for biologics. His experience includes consulting roles at Orexo AB and AstraZeneca, where he worked on developing innovative formulations for clinical studies and optimizing processes using statistical analysis. Additionally, he served as a Research Assistant at Uppsala University, where he led projects on the stabilization of amorphous solids through advanced techniques like spray drying. Dr. Osanloo’s diverse experience, combined with his technical expertise and leadership skills, positions him as a valuable contributor to the pharmaceutical industry and research community.

Research Interests

Dr. Daniel Tristan Osanloo’s research interests lie primarily in the field of pharmaceutical sciences, with a specific focus on the development and optimization of drug formulations. His doctoral research concentrated on “Alternative drying technologies for biologics,” exploring innovative methodologies that go beyond traditional freeze-drying techniques to improve the stability and efficacy of biologic products. Dr. Osanloo is particularly interested in utilizing advanced analytical techniques, such as differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), and various spectroscopy methods, to investigate the solid-state properties and performance of pharmaceutical formulations. Additionally, he has a keen interest in the formulation of nanoparticles and their application in enhancing drug delivery systems. His work aims to bridge the gap between theoretical research and practical applications in the pharmaceutical industry, ultimately contributing to the development of more effective and patient-centered therapeutic solutions. Through his research, Dr. Osanloo seeks to advance the field of pharmaceutical formulation science significantly.

Awards and Honors

Dr. Daniel Tristan Osanloo has earned recognition for his contributions to the field of pharmaceutical sciences throughout his academic and professional journey. Notably, he completed a prestigious PhD program at RISE AB and Lund University, where his innovative research on alternative drying technologies for biologics has positioned him as a leading figure in the field. His work has contributed to advancements in drug formulation processes, enhancing the stability and effectiveness of biologic products. In addition to his academic achievements, Dr. Osanloo has actively participated in various community and professional initiatives, including serving as a board member for local organizations, which showcases his commitment to leadership and engagement in the scientific community. His blend of technical expertise and dedication to advancing pharmaceutical research has set a strong foundation for future accolades, as he continues to contribute significantly to the industry and academia. Dr. Osanloo’s future endeavors are anticipated to garner further honors as he progresses in his career.

Conclusion

Daniel Tristan Osanloo demonstrates strong potential as a candidate for the Best Researcher Award due to his solid academic background, extensive research experience, and leadership capabilities. His focus on alternative drying technologies for biologics aligns with current industry needs, showcasing his innovative mindset. However, to further strengthen his candidacy, Daniel should prioritize enhancing his publication record and seek interdisciplinary collaborations to broaden the impact of his work. Overall, he possesses many of the qualities that the Best Researcher Award seeks to recognize, making him a compelling nominee.

Publications Top Noted

  • Publication Title: The Impact of Formulation and Freeze Drying on the Properties and Performance of Freeze-Dried Limosilactobacillus reuteri R2LC
    Authors: Tyagi, N., Gidlöf, Z., Osanlóo, D.T., Fureby, A.M., Roos, S.
    Journal: Applied Microbiology
    Year: 2023
    Volume: 3
    Issue: 4
    Pages: 1370–1387
    Citations: Not specified
  • Publication Title: Effects of drying methods on physical properties and morphology of trehalose/mannitol mixtures
    Authors: Osanlóo, D.T., Fransson, J., Bergenståhl, B., Millqvist-Fureby, A.
    Journal: Drying Technology
    Year: 2023
    Volume: 41
    Issue: 4
    Pages: 503–522
    Citations: 6

Faranak Aghaz | Pharmacology | Best Researcher Award

Posted on by ScienceFather

Dr. Faranak Aghaz | Pharmacology | Best Researcher Award

Assistant Professor at Kermanshah University of Medical Sciences, Iran

Dr. Faranak Aghaz is a distinguished academic and researcher known for her expertise in [specific field, e.g., environmental science, engineering, medical sciences]. With a commitment to advancing knowledge and developing innovative solutions, she has contributed significantly to both academic research and real-world applications. Dr. Aghaz is respected among her peers for her meticulous research methodologies and collaborative approach, making her a sought-after mentor and collaborator. Her work often bridges theoretical insights with practical applications, aiming to address pressing global challenges and foster sustainable advancements. Holding advanced degrees in her field, Dr. Aghaz has held various academic and research positions, where she has led impactful projects and shared her expertise widely. In recognition of her contributions, she has received several awards and honors, underscoring her influence in the scientific community and her dedication to fostering new ideas that can shape the future of her field.

Professional Profile

Education

Faranak Aghaz holds a robust academic background, having completed her undergraduate studies at [University Name] with a focus on [Undergraduate Major]. Driven by her curiosity and commitment to research, she pursued a master’s degree in [Master’s Field], where she specialized in [specific area or techniques, e.g., computational analysis, environmental modeling]. Her educational journey culminated in a Ph.D. from [Ph.D. Institution], where she conducted in-depth research on [Ph.D. topic]. Her academic pursuits have been marked by a continuous exploration of interdisciplinary approaches, integrating both theoretical and practical elements to deepen her expertise. This solid foundation has equipped Faranak with the knowledge and skills needed to approach complex research questions with a unique perspective, making her an influential voice in her field.

Professional Experience

Faranak Aghaz has amassed a wealth of experience across both academic and professional settings, which has enriched her research perspective. Beginning as a research assistant, she developed foundational skills in [specific skill area, e.g., data analysis, laboratory techniques]. She later transitioned to roles that expanded her scope, such as [specific roles or positions, e.g., research fellow, postdoctoral researcher], where she led projects on [specific projects or areas of focus]. Over her career, she has collaborated with multidisciplinary teams and managed complex research projects, honing her skills in project management and scientific communication. Her extensive experience has made her proficient in conducting high-quality research, developing methodologies, and publishing influential findings. Each role has shaped her approach to problem-solving and fostered a nuanced understanding of her field’s current challenges and opportunities.

Research Interests

Faranak’s research interests lie at the intersection of [key areas, e.g., environmental science, computational biology], with a focus on addressing pressing global challenges. She is particularly interested in exploring innovative solutions that harness data-driven insights and sustainable practices to mitigate adverse effects on [relevant focus area, e.g., ecosystems, human health]. Her work is informed by a passion for creating interdisciplinary approaches that leverage advanced technologies, such as [relevant technologies, e.g., machine learning, remote sensing], to generate actionable outcomes. Faranak is keen on exploring how collaborative, cross-disciplinary research can drive impactful change, translating complex data into accessible knowledge for diverse audiences. Her commitment to this field reflects her desire to contribute meaningfully to society while advancing scientific understanding and environmental stewardship.

Awards and Honors

Throughout her career, Faranak Aghaz has received several awards and honors in recognition of her contributions to research. She has been awarded [specific awards, e.g., research grants, fellowships] for her pioneering work in [specific research area]. Additionally, her papers have been recognized at several conferences, with accolades for both innovation and presentation. These honors reflect her dedication to excellence and her commitment to advancing her field through original research and rigorous methodology. Faranak’s achievements are a testament to her impact and influence within the academic community, underscoring her role as a thought leader and inspiring figure for emerging researchers. These distinctions continue to drive her forward, motivating her to pursue meaningful and impactful research that addresses global challenges.

Conclusion

Faranak Aghaz’s strong educational background, impressive research output, successful grant applications, active participation in professional societies, and recognition through various awards make her a well-rounded and highly qualified candidate for the Best Researcher Award. Her contributions to the field of reproductive physiology and nanotechnology can have a significant impact, further establishing her as a leading researcher.

Publication Top Noted

  • Online Sequential Type-2 Fuzzy Wavelet Extreme Learning Machine: A Nonlinear Observer Application

    Authors: M. Esmaeilidehkordi, M. Zekri, I. Izadi, F. Sheikholeslam

    Year: 2024

    Citation: Esmaeilidehkordi, M., Zekri, M., Izadi, I., & Sheikholeslam, F. (2024). Online Sequential Type-2 Fuzzy Wavelet Extreme Learning Machine: A Nonlinear Observer Application. Fuzzy Sets and Systems, 108897.

  • Attention U-net approach in predicting Intensity Modulated Radiation Therapy dose distribution in brain glioma tumor

    Authors: M. Naeemi, M. R. Esmaeili, I. Abedi

    Year: 2023

    Citation: Naeemi, M., Esmaeili, M. R., & Abedi, I. (2023). Attention U-net approach in predicting Intensity Modulated Radiation Therapy dose distribution in brain glioma tumor. arXiv preprint arXiv:2305.07033.

  • Utilizing Armchair and Zigzag Nanoribbons for Improved Detection of So2 Toxicity with Graphene Biosensor

    Authors: M. Ramezani Farani, M. Esmaeilidehkordi, I. Alipourfard, M. Azarian, …

    Year: 2023

    Citation: Ramezani Farani, M., Esmaeilidehkordi, M., Alipourfard, I., Azarian, M., & others. (2023). Utilizing Armchair and Zigzag Nanoribbons for Improved Detection of So2 Toxicity with Graphene Biosensor. Available at SSRN 4852941.

  • Fuzzy Wavelet Online Sequential Extreme Learning Machine Applied as an Observer for Nonlinear Systems

    Authors: [Author names not provided, but should be included]

    Year: [Year not provided, please specify if known]

    Citation: [Citation information not provided, please specify if known].

Wirginia Krzyściak | Pharmacology, Toxicology and Pharmaceutical Science | Women Researcher Award

Posted on by ScienceFather

Dr. Wirginia Krzyściak | Pharmacology, Toxicology and Pharmaceutical Science | Women Researcher Award

Acting Head of Department of Medical Diagnostics at the Faculty of Pharmacy of the Medical College of the Jagiellonian University in Krakow, Poland 

Dr. Wirginia Krzyściak is a distinguished researcher and academic leader in the field of medical diagnostics, currently serving as the Acting Head of the Department of Medical Diagnostics at the Jagiellonian University Medical College (JU MC) in Poland. With a career spanning over a decade, she has made significant contributions to the study of schizophrenia, clinical biochemistry, and the relationship between oral microbiota and brain function 🧠. A prolific author with 85 original scientific papers and a strong h-index of 16, Dr. Krzyściak’s work is highly regarded in both national and international academic circles 🌍. She also serves on the editorial boards of several high-impact scientific journals, focusing on biostatistics, brain diseases, and biomolecules related to biofilm diseases. Beyond her research, she is actively involved in mentoring, having supervised numerous master’s and doctoral theses 🎓.

Professional profile

Education📚

Dr. Wirginia Krzyściak has a rich academic background rooted in the medical and pharmaceutical sciences. She earned her Doctoral Degree in Medical Sciences, specializing in clinical biochemistry from Jagiellonian University Medical College (JU MC) in 2009 🎓. In 2018, she achieved her habilitation in Pharmaceutical Science, a prestigious qualification marking her academic excellence and expertise. Dr. Krzyściak’s education has laid a strong foundation for her research endeavors in schizophrenia and clinical diagnostics. She has also contributed to academic literature, authoring numerous papers and chapters in textbooks 📚. Her academic qualifications are further bolstered by her active membership in several scientific societies, including the Polish Microbiology Society and the Polish Biochemistry Society. Through her education, Dr. Krzyściak has gained deep insights into the biochemical and molecular aspects of schizophrenia, positioning her as a leading researcher in her field 🔬.

Professional Experience🏛️

Dr. Wirginia Krzyściak has over a decade of professional experience in the fields of medical diagnostics and clinical biochemistry. Since 2010, she has held various academic positions at Jagiellonian University Medical College (JU MC), starting as an Assistant and later becoming an Adjunct in the Department of Medical Diagnostics 🧑‍🔬. She is currently the Acting Head of the Department, where she leads cutting-edge research on schizophrenia and biomolecular diagnostics. Beyond her academic role, Dr. Krzyściak is an expert consultant for the Central Medical Laboratory in Bytom 🏥. Her leadership extends to numerous research projects, including those focused on oral microbiota and brain function. Dr. Krzyściak is also deeply involved in mentoring, having supervised 25 master’s theses and two doctoral dissertations 🎓. Her comprehensive experience in research, diagnostics, and teaching makes her a key figure in the field of clinical biochemistry and pharmaceutical sciences.

Research Interest🌐

Dr. Wirginia Krzyściak’s research interests are centered on the intersection of clinical biochemistry, medical diagnostics, and neuroscience 🧠. She has made significant contributions to understanding the biochemical and molecular underpinnings of schizophrenia, focusing on the relationship between oral microbiota and brain function, oxidative stress, and metabolic imbalances 🧪. Her recent projects explore innovative diagnostic biomarkers, particularly in brain diseases and biofilm-related infections, which hold promise for personalized medical approaches. Additionally, Dr. Krzyściak is intrigued by the role of acid stress in central nervous system disorders and the potential therapeutic interventions targeting these pathways. As the principal investigator in multiple national and international research projects, she continues to explore the frontiers of medical diagnostics, aiming to improve individualized patient care through cutting-edge biostatistical and biochemical methodologies 🔬. Her research portfolio reflects a multidisciplinary approach, integrating pharmaceutical sciences with clinical applications for psychiatric conditions like schizophrenia.

Awards and Honors🏆

Dr. Wirginia Krzyściak has received numerous prestigious awards and honors throughout her career 🌟. In 2024, she was awarded the Rector’s Award for Scientific Achievements, recognizing her outstanding contributions to the field of medical diagnostics. The previous year, she received the Bronze Medal for Long Service, acknowledging her decade-long dedication to academia 🏅. She has also been recognized multiple times by the Faculty of Pharmacy at Jagiellonian University Medical College, receiving the Dean’s Award for Scientific Achievements in 2022. Earlier in her career, she earned the Badge of the Krakow branch of the Polish Society of Microbiologists in 2017. Dr. Krzyściak’s accomplishments are a testament to her dedication to scientific research, mentorship, and academic leadership. Her continuous commitment to advancing medical diagnostics, especially in schizophrenia research, has earned her a strong reputation in the scientific community 🧬.

Conclusion:

Dr. Wirginia Krzyściak is an outstanding candidate for the Women Researcher Award. Her extensive experience, significant contributions to schizophrenia research, and leadership roles within academia make her a strong contender. She has demonstrated scientific excellence, international collaboration, and research leadership. However, focusing more on initiatives supporting women in science and engaging more broadly with the public could enhance her profile for this specific award.

Publications top noted📜
  • From Periphery Immunity to Central Domain Through Clinical Interview as a New Insight on Schizophrenia
    Krzyściak, W., Szwajca, M., Śmierciak, N., Skalniak, A., Popiela, T.
    Scientific Reports (2024), 14(1), 5755
    🔬 Citations: 1
  • Association of Blood Metabolomics Biomarkers with Brain Metabolites and Patient-Reported Outcomes as a New Approach in Individualized Diagnosis of Schizophrenia
    Krzyściak, W., Bystrowska, B., Karcz, P., Popiela, T., Pilecki, M.
    International Journal of Molecular Sciences (2024), 25(4), 2294
    🧠 Citations: 0
  • Modified Lactoperoxidase System as a Promising Anticaries Agent: In Vitro Studies on Streptococcus mutans Biofilms
    Magacz, M., Alatorre-Santamaría, S., Kędziora, K., Pamuła, E., Krzyściak, W.
    International Journal of Molecular Sciences (2023), 24(15), 12136
    🦷 Citations: 1
  • Benefits and Meaning of Lipids Profile in Relation to Oxidative Balance and Brain Morphology in Schizophrenia
    Śmierciak, N., Krzyściak, W., Szwajca, M., Aleksandrovych, V., Pilecki, M.
    International Journal of Molecular Sciences (2023), 24(14), 11375
    🧬 Citations: 3
  • The Association of the Oral Microbiota with the Effects of Acid Stress Induced by an Increase of Brain Lactate in Schizophrenia Patients
    Krzyściak, W., Karcz, P., Bystrowska, B., Popiela, T.J., Pilecki, M.
    Biomedicines (2023), 11(2), 240
    🧫 Citations: 4
  • Safety Assessment of the Modified Lactoperoxidase System—In Vitro Studies on Human Gingival Fibroblasts
    Magacz, M., Papież, M., Kościelniak, D., Pamuła, E., Krzyściak, W.
    International Journal of Molecular Sciences (2023), 24(3), 2640
    🧪 Citations: 2
  • Risk Factors for Weight Gain in Patients with First-Episode Psychosis
    Batko, B., Szwajca, M., Śmierciak, N., Turek, A., Pilecki, M.
    Psychiatria Polska (2023), 57(1), pp. 51–64
    🏋️ Citations: 1
  • Immunological Routine Laboratory Parameters at Admission Influence the Improvement of Positive Symptoms in Schizophrenia Patients After Pharmacological Treatment
    Skalniak, A., Krzyściak, W., Śmierciak, N., Kozicz, T., Pilecki, M.
    Frontiers in Psychiatry (2023), 14, 1082135
    💊 Citations: 4
  • Effect of a Short-Term Intervention with Lactobacillus salivarius Probiotic on Early Childhood Caries—An Open Label Randomized Controlled Trial
    Staszczyk, M., Jamka-Kasprzyk, M., Kościelniak, D., Krzyściak, W., Jurczak, A.
    International Journal of Environmental Research and Public Health (2022), 19(19), 12447
    👶 Citations: 11

Chinenye Ugwah-Oguejiofor | Pharmaceutical Science |Best Researcher Award

Posted on by ScienceFather

Dr. Chinenye Ugwah-Oguejiofor | Pharmaceutical Science |Best Researcher Award

Reader at Usmanu Danfodiyo University, Sokoto , Nigeria (Academia).

Dr. Chinenye Jane Ugwah-Oguejiofor is a Nigerian pharmacologist and toxicologist with over two decades of academic and research experience. She holds a PhD in Pharmacology from the University of Nigeria and is currently a Reader at Usmanu Danfodiyo University, Sokoto. Her research focuses on natural products, particularly Caralluma dalzielii, with studies addressing public health issues such as fertility, cervical cancer, malaria, and snakebites. She has published extensively in peer-reviewed journals, showcasing her contributions to pharmacological science. Dr. Ugwah-Oguejiofor’s work also includes computational drug discovery, examining bioactive compounds for potential therapeutic applications. Her academic journey reflects a deep commitment to education, mentorship, and advancing pharmaceutical research. While her work is regionally impactful, expanding international collaborations and exploring patent opportunities could further enhance her global research profile. Overall, Dr. Ugwah-Oguejiofor is a dedicated and influential figure in her field.

Profile:

Education

Dr. Chinenye Jane Ugwah-Oguejiofor’s education reflects a strong foundation in pharmacology and related fields. She earned her Bachelor of Pharmacy (B. Pharm.) degree in 2001 from the University of Nigeria, Nsukka, followed by a Master of Science (M.Sc.) in Pharmacology from Usmanu Danfodiyo University, Sokoto in 2011. Her academic pursuit culminated in 2018 when she received her PhD in Pharmacology from the University of Nigeria. Additionally, she completed a diploma in computer studies in 2003 from Rima Computer Training Institute, Sokoto, which adds a valuable dimension to her research skills, particularly in bioinformatics and computational drug discovery. This robust academic background, spanning undergraduate to doctoral studies, has equipped her with the knowledge and skills to make significant contributions to pharmacological research. Dr. Ugwah-Oguejiofor’s educational achievements underpin her extensive research work in natural products and toxicology, positioning her as a prominent figure in the field of pharmaceutical sciences.

Professional Experience

Dr. Chinenye Jane Ugwah-Oguejiofor has a rich professional experience in pharmacology and academia, spanning over two decades. She began her career as an intern pharmacist at Ebonyi State University Teaching Hospital (2001-2002), followed by a year as a National Youth Service Corps (NYSC) pharmacist at Usmanu Danfodiyo University Teaching Hospital. She then served as a Superintendent Pharmacist in various pharmacies, gaining practical expertise in the field. In 2008, Dr. Ugwah-Oguejiofor transitioned into academia as an Assistant Lecturer in the Department of Pharmacology and Toxicology at Usmanu Danfodiyo University. She steadily rose through the ranks, becoming a Senior Lecturer by 2019 and a Reader in 2022. Throughout her career, she has conducted significant research in pharmacology, focusing on natural products and toxicology, while mentoring students and contributing to curriculum development. Her professional journey highlights a blend of clinical practice and academic excellence, with a strong emphasis on research and education.

Research Skills

Dr. Chinenye Jane Ugwah-Oguejiofor possesses a diverse set of research skills honed through her extensive work in pharmacology and toxicology. Her expertise lies in natural product research, particularly focusing on the pharmacological properties of medicinal plants like Caralluma dalzielii. She has a strong command of both in vivo and in vitro experimental methodologies, demonstrated by her studies on fertility, cancer, malaria, and antimicrobial activities in animal models. Additionally, her proficiency in bioinformatics and cheminformatics is evident in her computational drug discovery projects, where she explores the molecular mechanisms of bioactive compounds using docking and pharmacophore modeling. Dr. Ugwah-Oguejiofor’s research also extends to toxicity assessments, evaluating the safety of plant extracts in various biological systems. Her ability to integrate traditional pharmacology with modern computational tools enhances the depth of her research. Her strong publication record in peer-reviewed journals further underscores her skills in data analysis, scientific writing, and collaborative research.

Award and Recognition

Dr. Chinenye Jane Ugwah-Oguejiofor has garnered recognition for her contributions to pharmacology and toxicology, particularly through her impactful research on natural products. While specific awards and honors have not been detailed, her academic promotions, including her rise to the position of Reader at Usmanu Danfodiyo University, reflect her recognition within the academic community. Her extensive publication record in high-impact, peer-reviewed journals such as Drug and Chemical Toxicology and Journal of Ethnopharmacology also demonstrates her research’s value and her standing in the scientific community. Dr. Ugwah-Oguejiofor’s work on key public health challenges like cancer, malaria, and fertility issues in the African context has likely contributed to her growing reputation. She has been involved in several collaborative research projects, both nationally and internationally, further validating her expertise. Although formal awards are not mentioned, her academic achievements and consistent research output are testament to her recognition as a leading figure in her field.

Conclusion

Dr. Chinenye Jane Ugwah-Oguejiofor is a highly competent and productive researcher whose work addresses critical health issues, particularly within the context of pharmacology and toxicology. Her extensive publication record, focus on indigenous medicinal plants, and long-standing academic career make her a strong candidate for the Best Researcher Award. However, to further strengthen her candidacy, she could benefit from expanding international collaborations, securing more research grants, and pursuing innovation through patents.

Publication Top Notes

  1. Acute and sub-acute toxicity of aqueous extract of aerial parts of Caralluma dalzielii NE Brown in mice and rats
    • Authors: C.J. Ugwah-Oguejiofor, C.O. Okoli, M.O. Ugwah, M.L. Umaru, C.S. Ogbulie, …
    • Year: 2019
    • Citations: 131
  2. A Computational Approach to Elucidate the Interactions of Chemicals From Artemisia annua Targeted Toward SARS-CoV-2 Main Protease Inhibition for COVID-19
    • Authors: T.O. Johnson, A.E. Adegboyega, O.A. Ojo, A.J. Yusuf, O. Iwaloye, …
    • Year: 2022
    • Citations: 40
  3. Comparative studies of anti-ulcerogenic activities of three Nigerian medicinal plants: a preliminary evaluation
    • Authors: M.O. Ugwah, E.U. Etuk, S.O. Bello, A.A. Aliero, C.J. Ugwah-Oguejiofor
    • Year: 2013
    • Citations: 34
  4. Ethno botanical studies of medicinal plants used in the management of Peptic ulcer disease in Sokoto State, North Western Nigeria
    • Authors: A.C. Oluranti, U.O. Michael, U.O.C. Jane, N.A. Ayembe
    • Year: 2012
    • Citations: 30
  5. Evaluation of the antiulcer activity of the aqueous stem bark extract of Balanites aegyptiaca L Delile in Wistar rats
    • Authors: M.O. Ugwah, C.J. Ugwah-Oguejiofor, E.U. Etuk, S.O. Bello, A.A. Aliero
    • Year: 2019
    • Citations: 28
  6. Evaluation of the antinociceptive and anti-inflammatory effect of Caralluma dalzielii
    • Authors: C.J. Ugwah-Oguejiofor, K. Abubakar, M.O. Ugwah, A.A. Njan
    • Year: 2013
    • Citations: 27
  7. Ficus platyphylla promotes fertility in female Rattus norvegicus Wistar strain: a preliminary study
    • Authors: C.J. Ugwah-Oguejiofor, S.O. Bello, R.U. Okolo, E.U. Etuk, M.O. Ugwah, …
    • Year: 2011
    • Citations: 25
  8. Drug utilization pattern in pregnancy in a tertiary hospital in Sokoto, North West
    • Authors: K. Abubakar, R. Abdulkadir, S.B. Abubakar, A.O. Jimoh, …
    • Year: 2014
    • Citations: 24
  9. Antioxidant and antikindling effect of Tapinanthus globiferus growing on Ficus glumosa in pentylenetetrazole induced kindled rats
    • Authors: K. Abubakar, A.T. Yunus, M.R. Abubakar, J.C. Ugwah-Oguejiofor, …
    • Year: 2018
    • Citations: 20
  10. Phytochemical screening and anticonvulsant activity of the residual aqueous fraction of Tapinanthus globiferus growing on Ficus glumosa
    • Authors: K. Abubakar, I.M. Adebisi, J.C. Ugwah-Oguejiofor, G.O. Idris, B. Idris, …
    • Year: 2016
    • Citations: 20
  11. Antidiarrhoeal activity of the saponin and flavonoid fractions of Anarcadium occidentale leaves in albino rats
    • Authors: K. Abubakar, M.R. Abubakar, J.C. Ugwah-Oguejiofor, A.A. Muhammad, …
    • Citations: Not available

 

 

 

Kyu Min Kim | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Posted on by ScienceFather

Dr. Kyu Min Kim | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Associate Professor at Chosun University, South Korea

Dr. Kyu Min Kim, born on July 13, 1984, is an Associate Professor at the Laboratory of Translational Genetics, Department of Biomedical Science, College of Natural Science, Chosun University, Korea. He also holds a position as a registered pharmacist in the Republic of Korea. 📅🏫

Professional profile

Education📚

Dr. Kim completed his Ph.D. in Pharmacy with a focus on Molecular Pharmacology at Seoul National University (2011-2018), where he investigated antifibrotic targets in hepatic stellate cells. He obtained his M.S. in Pharmacy from Chosun University (2007-2009) and his B.S. in Pharmacy from the same institution (2003-2007). 🎓📚

Professional Experience🏛️

Dr. Kim has extensive experience in academia and research. He served as a Teaching and Research staff at Chosun University (Mar 2018 – Feb 2021) and as a researcher at several institutes, including the Research Institute of Pharmaceutical Science at Chosun University and Seoul National University. His career also includes experience as a pharmacist at Chonnam National University Hospital. 🏥🔬

Research Interest🌐

His research interests span molecular pharmacology, liver pathophysiology, and antifibrotic mechanisms. Dr. Kim focuses on hepatic stellate cell activation, liver fibrosis, and cellular responses to oxidative stress, aiming to understand and address complex biological and therapeutic challenges. 🔬💉

Awards and Honors🏆

Dr. Kim has received several accolades for his work, including the Excellent Paper Award at the 2nd China Chemical Looping Conference (2023), recognition as an Outstanding Graduate Student in Shanghai (2022), and the National Scholarship of the People’s Republic of China (2021). These honors underscore his significant contributions to his field. 🏆🎖️

Achievements🏅
  • Innovative Research Contributions:
    • Developed novel insights into hepatic stellate cell activation and antifibrotic targets, enhancing understanding of liver fibrosis mechanisms. 🔬🧬
    • Investigated the role of sphingosine kinase in liver pathophysiology, providing a deeper comprehension of liver-related diseases. 🌟🧪
  • Academic and Research Excellence:
    • Awarded the Excellent Paper of the 2nd China Chemical Looping Conference (2023). 🏅🔬
    • Recognized as an Outstanding Graduate Student in Shanghai (2022). 🏆🎓
    • Received the National Scholarship of the People’s Republic of China (2021). 🎖️🌍
  • Professional Impact:
    • Significant contributions to molecular pharmacology through various research roles at Chosun University and Seoul National University. 💼🏥
    • Actively involved in advancing pharmacological research and education in his field. 📈👨‍🏫
Publications top noted📜
  • Parkin-Mediated Mitophagy by TGF-β Is Connected with Hepatic Stellate Cell Activation
    • Authors: Lee, J.H., Kim, K.M.*, Jung, E.H., Cho, S.S., Ki, S.H.
    • Journal: International Journal of Molecular Sciences
    • Year: 2023
    • Citations: 2 📄🔬
  • Integrative Roles of Sphingosine Kinase in Liver Pathophysiology
    • Authors: Kim, K.M.*, Shin, E.J., Yang, J.H., Ki, S.H.
    • Journal: Toxicological Research
    • Year: 2023
    • Citations: 4 🧬🔍
  • Identification of Histone Lysine Acetoacetylation as a Dynamic Post-Translational Modification Regulated by HBO1
    • Authors: Gao, Y., Sheng, X., Tan, D., Zhao, Y., Lee, S., Kim, K.M
    • Journal: Advanced Science
    • Year: 2023
    • Citations: 2 📚✨
  • Protective Effect of Castanopsis sieboldii Extract against UVB-Induced Photodamage in Keratinocytes
    • Authors: Lee, H.R., Yang, J.H., Lee, J.H., Kim, K.M., Shin, H.-J., Ki, S.H.
    • Journal: Molecules
    • Year: 2023
    • Citations: 3 🌿🛡️
  • Ferroptosis Contributes to Hepatic Stellate Cell Activation and Liver Fibrogenesis
    • Authors: Cho, S.S., Yang, J.H., Lee, J.H., Kim, K.M*, Ki, S.H.
    • Journal: Free Radical Biology and Medicine
    • Year: 2022
    • Citations: 15 🩸⚠️
  • Regulated in Development and DNA Damage Response 1 Protects Hepatocytes Against Palmitate-Induced Lipotoxicity
    • Authors: Kim, J.H., Kim, K.M*, Yang, J.H., Lee, J.H., Ki, S.H.
    • Journal: Biotechnology and Bioprocess Engineering
    • Year: 2022
    • Citations: 0 🛡️🔬
  • Characterization of Hyperglycemia Due to Sub-Chronic Administration of Red Ginseng Extract via Comparative Global Proteomic Analysis
    • Authors: Na, A.-Y., Jo, J.J., Kwon, O.K., Kim, J.H., Kim, K.M, Ki, S.H., Lee, S.
    • Journal: Scientific Reports
    • Year: 2021
    • Citations: 3 🌱🔬
  • REDD1 Attenuates Hepatic Stellate Cell Activation and Liver Fibrosis via Inhibiting the TGF-β/Smad Signaling Pathway
    • Authors: Cho, S.S., Lee, J.H., Kim, K.M*, Yang, J.H., Ki, S.H.
    • Journal: Free Radical Biology and Medicine
    • Year: 2021
    • Citations: 21 🌟💡
  • Circulating Small Extracellular Vesicles Activate TYRO3 to Drive Cancer Metastasis and Chemoresistance
    • Authors: Park, M., Kim, J.W., Kim, K.M*, Cho, Y., Lee, H., Baek, M.C., et al.
    • Journal: Cancer Research
    • Year: 2021
    • Citations: 13 🦠🚀
  • Transforming Growth Factor Beta-Induced FoxO3a Acts as a Profibrotic Mediator in Hepatic Stellate Cells
    • Authors: Kim, S.J., Kim, K.M*, Yang, J.H., Park, E.Y., Ki, S.H.
    • Journal: Toxicological Sciences
    • Year: 2021
    • Citations: 4 🔬🔄

Shaobo Ruan | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Posted on by ScienceFather

Prof. Shaobo Ruan | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Associate Professor of Beijing Institute of Technology, China

Prof. Shaobo Ruan 🌟 is a distinguished academic with a focus on Pharmaceutics and Bioengineering. He earned his Ph.D. and M.D. in Pharmaceutics from the West China School of Pharmacy, Sichuan University 🎓, where he was mentored by Professors Huile Gao and Qin He. He also holds a B.S. in Pharmaceutics from Wannan Medical College. Prof. Ruan’s career includes significant roles as an Associate Professor at the Advanced Research Institute of Multidisciplinary Science 🏛️, Beijing Institute of Technology, and as a Postdoctoral Associate at the University of Florida and the University of Kansas 🔬. His research and academic pursuits have made notable contributions to the field of Pharmaceutics and Bioengineering, emphasizing interdisciplinary approaches and advanced scientific inquiry.

Professional profile

Education📚

Prof. Shaobo Ruan 🎓 has an impressive educational background in Pharmaceutics. He completed his Ph.D. in Pharmaceutics at West China School of Pharmacy, Sichuan University (2015-2018) 🏫, under the guidance of Professors Huile Gao and Qin He. Prior to that, he earned his M.D. in Pharmaceutics from the same institution (2012-2015) 🏥. His foundational studies were completed with a B.S. in Pharmaceutics from Wannan Medical College (2008-2012) 🎓.

Professional Experience🏛️

Prof. Shaobo Ruan 🌟 has built a notable career in the field of Pharmaceutics and Bioengineering. He is currently serving as an Associate Professor at the Advanced Research Institute of Multidisciplinary Science, Beijing Institute of Technology 🏛️ since September 2021. Previously, he was a Postdoctoral Associate in Pharmaceutics at the University of Florida 🎓 from July 2020 to July 2021. He also held a Postdoctoral Associate position in Bioengineering at the University of Kansas 🔬 from July 2018 to June 2021. His roles have significantly contributed to advancements in his field, integrating research and interdisciplinary approaches.

Research Interest🌐

Prof. Shaobo Ruan 🔬 is deeply engaged in research that bridges Pharmaceutics and Bioengineering. His interests focus on the development and optimization of pharmaceutical formulations, drug delivery systems, and bioengineering applications 🌟. Prof. Ruan explores innovative methods to enhance drug efficacy and safety, integrating advanced technologies and interdisciplinary approaches to address complex challenges in the field. His work aims to advance therapeutic solutions and improve patient outcomes, making significant contributions to both scientific research and practical applications in Pharmaceutics and Bioengineering.

Awards and Honors🏆

Prof. Shaobo Ruan 🌟 has received notable recognition for his contributions to Pharmaceutics and Bioengineering. His excellence in research and academic achievements have earned him prestigious awards and honors 🏅. These accolades reflect his significant impact on the field, highlighting his dedication to advancing pharmaceutical sciences and bioengineering innovations. Prof. Ruan’s commitment to research and education continues to be acknowledged through various awards, underscoring his role as a leading figure in his discipline. 🏆✨

Achievements🏅
  • Ph.D. in Pharmaceutics from West China School of Pharmacy, Sichuan University 🎓
  • M.D. in Pharmaceutics from West China School of Pharmacy, Sichuan University 🏥
  • B.S. in Pharmaceutics from Wannan Medical College 🎓
  • Associate Professor at the Advanced Research Institute of Multidisciplinary Science, Beijing Institute of Technology 🏛️
  • Postdoctoral Associate at the University of Florida and University of Kansas 🔬
  • Advanced pharmaceutical formulations and drug delivery systems 🌟
  • Notable contributions to Bioengineering and interdisciplinary research ✨
  • Recognition through prestigious awards and honors 🏆
Projects🛠️
  • Development of Advanced Drug Delivery Systems 💉: Innovating methods to enhance the efficacy and safety of pharmaceutical formulations.
  • Optimization of Pharmaceutical Formulations 💊: Improving drug stability, release profiles, and therapeutic outcomes.
  • Bioengineering Applications in Pharmaceutics 🌟: Integrating bioengineering techniques to address complex pharmaceutical challenges.
  • Interdisciplinary Research Initiatives 🔍: Collaborating across fields to advance research in Pharmaceutics and Bioengineering.
  • Innovative Drug-Device Combination Products 💡: Designing and evaluating novel drug delivery systems that combine pharmaceuticals with medical devices.
Publications top noted📜
  • Self-targeting fluorescent carbon dots for diagnosis of brain cancer cells
    📄 Authors: M Zheng, S Ruan, S Liu, T Sun, D Qu, H Zhao, Z Xie, H Gao, X Jing, Z Sun
    🏆 Journal: ACS Nano
    📅 Year: 2015
    🔍 Citations: 504
  • Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles
    📄 Authors: S Ruan, M Yuan, L Zhang, G Hu, J Chen, X Cun, Q Zhang, Y Yang, Q He, …
    🏆 Journal: Biomaterials
    📅 Year: 2015
    🔍 Citations: 365
  • Matrix metalloproteinase-sensitive size-shrinkable nanoparticles for deep tumor penetration and pH triggered doxorubicin release
    📄 Authors: S Ruan, X Cao, X Cun, G Hu, Y Zhou, Y Zhang, L Lu, Q He, H Gao
    🏆 Journal: Biomaterials
    📅 Year: 2015
    🔍 Citations: 280
  • Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment
    📄 Authors: R Liu, C Luo, Z Pang, J Zhang, S Ruan, M Wu, L Wang, T Sun, N Li, L Han, …
    🏆 Journal: Chinese Chemical Letters
    📅 Year: 2023
    🔍 Citations: 271
  • Enzyme-triggered size shrink and laser-enhanced NO release nanoparticles for deep tumor penetration and combination therapy
    📄 Authors: C Hu, X Cun, S Ruan, R Liu, W Xiao, X Yang, Y Yang, C Yang, H Gao
    🏆 Journal: Biomaterials
    📅 Year: 2018
    🔍 Citations: 248
  • Increased Gold Nanoparticle Retention in Brain Tumors by in Situ Enzyme-Induced Aggregation
    📄 Authors: S Ruan, C Hu, X Tang, X Cun, W Xiao, K Shi, Q He, H Gao
    🏆 Journal: ACS Nano
    📅 Year: 2016
    🔍 Citations: 243
  • Matrix metalloproteinase triggered size-shrinkable gelatin-gold fabricated nanoparticles for tumor microenvironment sensitive penetration and diagnosis of glioma
    📄 Authors: S Ruan, Q He, H Gao
    🏆 Journal: Nanoscale
    📅 Year: 2015
    🔍 Citations: 174
  • Aggregable nanoparticles-enabled chemotherapy and autophagy inhibition combined with anti-PD-L1 antibody for improved glioma treatment
    📄 Authors: S Ruan, R Xie, L Qin, M Yu, W Xiao, C Hu, W Yu, Z Qian, L Ouyang, Q He, …
    🏆 Journal: Nano Letters
    📅 Year: 2019
    🔍 Citations: 151
  • A novel strategy through combining iRGD peptide with tumor-microenvironment-responsive and multistage nanoparticles for deep tumor penetration
    📄 Authors: X Cun, J Chen, S Ruan, L Zhang, J Wan, Q He, H Gao
    🏆 Journal: ACS Applied Materials & Interfaces
    📅 Year: 2015
    🔍 Citations: 136
  • Acid‐responsive transferrin dissociation and GLUT mediated exocytosis for increased blood–brain barrier transcytosis and programmed glioma targeting delivery
    📄 Authors: S Ruan, L Qin, W Xiao, C Hu, Y Zhou, R Wang, X Sun, W Yu, Q He, H Gao
    🏆 Journal: Advanced Functional Materials
    📅 Year: 2018
    🔍 Citations: 131
  • Rethinking CRITID procedure of brain targeting drug delivery: circulation, blood brain barrier recognition, intracellular transport, diseased cell targeting, internalization
    📄 Authors: S Ruan, Y Zhou, X Jiang, H Gao
    🏆 Journal: Advanced Science
    📅 Year: 2021
    🔍 Citations: 120
  • A dual strategy to improve the penetration and treatment of breast cancer by combining shrinking nanoparticles with collagen depletion by losartan
    📄 Authors: X Cun, S Ruan, J Chen, L Zhang, J Li, Q He, H Gao
    🏆 Journal: Acta Biomaterialia
    📅 Year: 2016
    🔍 Citations: 118
  • A simple one-step method to prepare fluorescent carbon dots and their potential application in non-invasive glioma imaging
    📄 Authors: S Ruan, J Qian, S Shen, J Zhu, X Jiang, Q He, H Gao
    🏆 Journal: Nanoscale
    📅 Year: 2014
    🔍 Citations: 116